Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiandong Han

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Psychiatry|June 20, 2022
Persistent Depressive Symptoms and the Changes in Serum Cystatin C Levels in the Elderly: A Longitudinal Cohort StudyTiandong Han, Li Zhang, Weixing Jiang, et al.
International Journal of Clinical and Experimental Pathology|December 1, 2015
Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinomaDonghao Shang, Tiandong Han, Xiuhong Xu, et al.
World Journal of Surgical Oncology|September 7, 2012
Gene expression profiling of the synergy of 5-aza-2'-deoxycytidine and paclitaxel against renal cell carcinomaTiandong Han, Donghao Shang, Xiuhong Xu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 24, 2017
VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinomaDonghao Shang, Shaozhong Xian, Tiandong Han, et al.
Archivos Espanoles De Urologia|June 10, 2026
A Retrospective Follow-up Study on the Effects of Different Intravesical Treatments on Recurrence Control and Quality of Life in Patients With Non-Muscle-Invasive Bladder Cancer After Transurethral Resection of Bladder TumourFangming Liu, Xinyi Hu, Xi Zhu, et al.
Cancer Letters|September 2, 2011
5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expressionDonghao Shang, Yuting Liu, Xiuhong Xu, et al.
Experimental and Therapeutic Medicine|June 20, 2014
Interferon-α enhances the susceptibility of renal cell carcinoma to rapamycin by suppressing mTOR activityXiao Han, Donghao Shang, Tiandong Han, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2017
VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinomaDonghao Shang, Shaozhong Xian, Tiandong Han, et al.
Translational Andrology and Urology|February 26, 2024
Machine learning algorithms being an auxiliary tool to predict the overall survival of patients with renal cell carcinoma using the SEER databaseWeixing Jiang, Zhenghao Chen, Cancan Chen, et al.
Experimental Biology and Medicine (Maywood, N.J.)|September 17, 2016
Flexible ureteroscopic lithotripsy for the treatment of upper urinary tract calculi in infantsJun Li, Jing Xiao, Tiandong Han, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Psychiatry|June 20, 2022
Persistent Depressive Symptoms and the Changes in Serum Cystatin C Levels in the Elderly: A Longitudinal Cohort StudyTiandong Han, Li Zhang, Weixing Jiang, et al.
International Journal of Clinical and Experimental Pathology|December 1, 2015
Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinomaDonghao Shang, Tiandong Han, Xiuhong Xu, et al.
World Journal of Surgical Oncology|September 7, 2012
Gene expression profiling of the synergy of 5-aza-2'-deoxycytidine and paclitaxel against renal cell carcinomaTiandong Han, Donghao Shang, Xiuhong Xu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 24, 2017
VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinomaDonghao Shang, Shaozhong Xian, Tiandong Han, et al.
Archivos Espanoles De Urologia|June 10, 2026
A Retrospective Follow-up Study on the Effects of Different Intravesical Treatments on Recurrence Control and Quality of Life in Patients With Non-Muscle-Invasive Bladder Cancer After Transurethral Resection of Bladder TumourFangming Liu, Xinyi Hu, Xi Zhu, et al.
Cancer Letters|September 2, 2011
5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expressionDonghao Shang, Yuting Liu, Xiuhong Xu, et al.
Experimental and Therapeutic Medicine|June 20, 2014
Interferon-α enhances the susceptibility of renal cell carcinoma to rapamycin by suppressing mTOR activityXiao Han, Donghao Shang, Tiandong Han, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2017
VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinomaDonghao Shang, Shaozhong Xian, Tiandong Han, et al.
Translational Andrology and Urology|February 26, 2024
Machine learning algorithms being an auxiliary tool to predict the overall survival of patients with renal cell carcinoma using the SEER databaseWeixing Jiang, Zhenghao Chen, Cancan Chen, et al.
Experimental Biology and Medicine (Maywood, N.J.)|September 17, 2016
Flexible ureteroscopic lithotripsy for the treatment of upper urinary tract calculi in infantsJun Li, Jing Xiao, Tiandong Han, et al.
Pageof 2